Literature DB >> 15208363

Corticotropin-releasing factor 2 receptor localization in skeletal muscle.

Steven Samuelsson1, Jana S Lange, Richard T Hinkle, Mark Tarnopolsky, Robert J Isfort.   

Abstract

Our objective in this study was to localize the corticotropin-releasing factor 2 receptor (CRF2R) in rodent and human skeletal muscle. We found CRF2R protein to be abundant in neural tissues in skeletal muscle, including large nerve fibers and bundles, neural tissue associated with mechanoreceptors, muscle spindles, and the Golgi tendon organ. CRF2R protein was also abundant in blood vessels in skeletal muscle. CRF2R protein was also observed, although with less abundance, in the endo/perimysial regions in skeletal muscle. The localization of the CRF2R to blood vessels is consistent with the CRF2R-mediated vascular phenomena observed previously, but the observation of CRF2R in neural tissue in skeletal muscle is a novel finding with an unknown function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15208363     DOI: 10.1369/jhc.4A6279.2004

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  4 in total

1.  Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus.

Authors:  S Vincent Wu; Pu-qing Yuan; Lixin Wang; Yen L Peng; Chih-Yen Chen; Yvette Taché
Journal:  Endocrinology       Date:  2007-01-11       Impact factor: 4.736

Review 2.  The peripheral corticotropin-releasing factor (CRF)-induced analgesic effect on somatic pain sensitivity in conscious rats: involving CRF, opioid and glucocorticoid receptors.

Authors:  Natalia I Yarushkina; Ludmila P Filaretova
Journal:  Inflammopharmacology       Date:  2018-02-05       Impact factor: 4.473

3.  Expression and regulation of corticotropin-releasing factor receptor type 2β in developing and mature mouse skeletal muscle.

Authors:  Yael Kuperman; Orna Issler; Joan Vaughan; Louise Bilezikjian; Wylie Vale; Alon Chen
Journal:  Mol Endocrinol       Date:  2010-11-17

4.  Latrotoxin-Induced Neuromuscular Junction Degeneration Reveals Urocortin 2 as a Critical Contributor to Motor Axon Terminal Regeneration.

Authors:  Giorgia D'Este; Marco Stazi; Samuele Negro; Aram Megighian; Florigio Lista; Ornella Rossetto; Cesare Montecucco; Michela Rigoni; Marco Pirazzini
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.